‹ ›
MYP_117225
← PREVIOUS NEXT → BACK
Basic Information
DENV Envelope glycoprotein (25-41)
Anticancer ▸ Cytotoxic anticancer activity ▸ Cytotoxic
Antimicrobial
Antiviral
Antiviral ▸ Anti-Flavivirus ▸ Anti-Dengue virus
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Venom / Toxin ▸ General toxin ▸ Cytotoxic
Standard
17 amino acids
C77H131N21O26S2
Standard
Sequence
LEHGSCVTTMAKDKPTL
Physicochemical Analysis
1831.12 Da
6.74
-0.16
-0.43
-0.0095
-0.29
0.34
-0.00
6.45
68.82
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
756.37
-8.56
27.0
29.0
60.0
126.0
2.0
16.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0071109 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-DENV Entry inhibition
DENV-3 | Vero cells
20 μM
% inhibition
Mammalian: 5.5 h; Yeast: 3 min; E. coli: 2 min
PaperIn vitro analysis of synthetic peptides in blocking the entry of dengue virus. | John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P. | Virus Res. 2019 Jan 15;260:142-150. | DOI:10.1016/j.virusres.2018.11.016 | PMID:30508603 PMID30508603 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30508603/
RECORD: Rec_0122416 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-DENV Entry inhibition
DENV-4 | Vero cells
20 μM
% inhibition
Mammalian: 5.5 h; Yeast: 3 min; E. coli: 2 min
PaperIn vitro analysis of synthetic peptides in blocking the entry of dengue virus. | John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P. | Virus Res. 2019 Jan 15;260:142-150. | DOI:10.1016/j.virusres.2018.11.016 | PMID:30508603 PMID30508603 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30508603/
RECORD: Rec_0207453 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
DENV-3
PMID30508603 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30508603/
RECORD: Rec_0214933 VERIFIED: YES
Provenance & Taxonomy
Dengue virus [Virus]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
DENV-2
PMID30508603 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30508603/
RECORD: Rec_0247373 VERIFIED: YES
Provenance & Taxonomy
Dengue virus [Virus]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
DENV-4
PMID30508603 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30508603/
1 2 3 NEXT LAST
Showing 5 records on this page · Page 1 of 3